Publications

Molecular design of a therapeutic LSD analogue with reduced hallucinogenic potential

 88
Molecular design of a therapeutic LSD analogue with reduced hallucinogenic potential

Tags:

Previous Article

Interplay between mesothelial and immune cells in the tumor microenvironment

Next Article

LSD analogue with potential for treating schizophrenia

Related Posts

BATF2 is a regulator of interferon-g signaling in astrocytes during neuroinflammation

BATF2 is a regulator of interferon-g signaling in astro...

 92

Protein-based molecular imprinting: gelatin nanotraps for interleukin-6 sequestration in inflammation cell models

Protein-based molecular imprinting: gelatin nanotraps f...

 68

Engineering the glioblastoma microenvironment using TLR7/8 agonist-complexed graphene oxide nanosheets

Engineering the glioblastoma microenvironment using TLR...

 64